Incremental innovation in mental health 'needs recognition'
This article was originally published in Scrip
Executive Summary
The CEO of Lundbeck, Ulf Wiinberg, is warning that the withdrawal of pharma from drug discovery in the mental health space could leave the world vulnerable in a similar manner as pharma's withdrawal from antibiotic development some years ago has done.